OXALIPLATIN
Clinical trials for OXALIPLATIN explained in plain language.
Never miss a new study
Get alerted when new OXALIPLATIN trials appear
Sign up with your email to follow new studies for OXALIPLATIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop liver cancer from coming back
Disease control CompletedThis study tests whether adding a targeted drug (Donafenib) and chemotherapy directly into the liver's blood supply can prevent liver cancer from returning after surgery. It includes adults with a single large tumor (≥5 cm) and microscopic blood vessel invasion, who are at high r…
Matched conditions: OXALIPLATIN
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New combo attack on rectal cancer: chemo plus targeted surgery shows promise
Disease control CompletedThis study looked at 180 people with rectal cancer that had spread to lymph nodes in the pelvis. One group received a three-drug chemotherapy regimen (FOLFOXIRI) followed by surgery to remove the affected lymph nodes. The other group got standard chemoradiotherapy before surgery.…
Matched conditions: OXALIPLATIN
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Shocking relief? electrostulation and compression soothe chemo nerve pain
Symptom relief CompletedThis study tested whether electrostimulation and compression can reduce nerve pain and improve quality of life in people with gastrointestinal cancer who developed peripheral neuropathy from oxaliplatin chemotherapy. 140 patients were split into four groups: control, electrostimu…
Matched conditions: OXALIPLATIN
Phase: NA • Sponsor: Cumhuriyet University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC